Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 17, 2020 07:30 ET | Source: ContraFect Corporation

Contrafect Announces Publication of Exebacase Phase 2 Study Results in the Journal of Clinical Investigation

Phase 2 study results demonstrated the potential clinical benefit of exebacase, when used in addition to existing antibiotics, for the treatment of life-threatening MRSA bacteremia Exebacase Phase...